Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical organizations, such as the makers of Xarelto, have a duty to ensure that their drugs are reasonably secure for use - and failure to do so may possibly be grounds for compensation. Our lawyers are working hard to acquire those hurt by the drug the compensation they http://servizi01.eu/ - http://servizi01.eu/adstreet/000/crafnm/2013/03/24/sezione-sorriso-destinazione-5-per-mille-modelli-730-2013/ are entitled to.<br><br> <br><br> Even though bleeding is actually a frequent complication related with anticoagulants, it has been alleged that Xarelto is far more harmful - http://Www.foxnews.com/search-results/search?q=harmful than classic blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This indicates that, within the event of an emergency, patients may possibly be at threat for irreversible bleeding difficulties, including life-threatening internal and gastrointestinal hemorrhaging.<br><br> <br><br> In the event you or even a loved 1 suffered a critical bleeding event following taking Xarelto, you might have legal recourse. For a lot more details, make contact with us right now to possess your case reviewed, free of charge of charge.<br><br> Compensation Possibilities<br><br> <br><br> xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for past and future medical bills, lost wages, discomfort and suffering and, in circumstances of death, funeral expenses. Additionally, they are in search of punitive damages, which are generally awarded to punish the defendant and deter other firms from acting similarly.<br><br> Why Are Lawsuits Being Filed?<br><br> <br><br> Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs within the lawsuits allege significant and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.<br><br> <br><br> In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:<br><br> <br><br> The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.<br><br> The makers of the drug continue to market Xarelto as a protected anticoagulant option.<br><br> Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.<br><br> Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.<br><br> Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.<br><br> <br><br> Visit this page for more information on the alleged health risks of Xarelto.<br><br> Multidistrict Litigation Trial Dates Set<br><br> <br><br> The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.